One of the things a good newsmagazine should do is provide contrasting opinions on important issues. It is something we try to achieve with nearly every article we carry.
One of the things a good newsmagazine should do is provide contrasting opinions on important issues. It is something we try to achieve with nearly every article we carry.
On rare occasions, we have the opportunity to present side-by-side contrasting viewpoints on a timely topic. This month is one of those occasions.
Beginning on page 51, you'll find a point/counterpoint presentation on the future of SPECT imaging and whether it will be supplanted by PET.
Dr. Abass Alavi and Dr. Stanley Goldsmith articulate the pro (PET) and con (SPECT) positions. The articles were commissioned by DI news editor C.P. Kaiser.
The debate is an ideal one for the June issue, which traditionally has a nuclear medicine focus and is distributed at the Society of Nuclear Medicine meeting that takes place this month.
Whether you end up agreeing with Alavi that PET is already replacing SPECT in many indications and will soon take over all of them, or with Goldsmith that SPECT will play an important role in nuclear medicine for many years to come, I think you'll find the discussion enlightening from both a clinical and an economic perspective.
I think you'll also find the discussion contains useful information for both nuclear medicine physicians and the radiologists who practice nuclear medicine on a part-time basis.
John C. Hayes is editor of Diagnostic Imaging
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.